The cure has been found ; )
The MD in the presentation doesn't mention the word "cure". He also says they enroll patients" selectively and cautiously";)
He has published paper: "A Novel Immuno-Chemotherapy: Inducing Long-term Remissions without Side Effects by Kenneth Matsumura* ALIN Foundation" http://jmbio.org/article.php
I exaggerated it on purpose ; annoncing 90% response on stage 3/4 cancer is close to annonce a cure ; the way the video is made sonds very official.
Unfortunately I'm not sure there is a lot of science that support this... I wish I was wrong
I made a mistake with the link to the paper, there doesn't seem to be a way to directly link to it, but here's a way to quickly find it:
I haven't read the entire paper yet, I will later, but I don't see anything wrong here so far. You often see high response rates with chemo(carboplatin, FDA approved in 1978), for example in ovarian cancer, many patients experience good responses that last months to several years.
He uses sodium phenylbutyrate to enhance chemotherapy. Phenylbutyrate is a strong HDAC inhibitor.
Using some type of immunotherapy in conjunction with chemotherapy, to me seems like a good strategy to use in conjunction with chemo.
In fact, this treatment strategy looks so similar to my father-in-law's treatment for Glioblastoma(stage 4 terminal brain cancer). He is alive and well 17 years after his DX (CCNU+Tamoxifen+Melatonin 15mg+A10). When phenylbutyrate is metabolized in the body it produces byproducts, one is antineoplaston A10. And, Melatonin has a profound impact on the immune system.
sorry, cisplatin is the older platin-based drug, carboplatin is a bit more recent (FDA 1991)
Wonder if he has deeper knowledge about Antonio Bru`s Neupogen protocol?
There is one more discussion on this subject as one of our friends (Meech) did this therapy 2 years ago https://www.cancertreatmentsresearch.com/community/main-forum/medicor-safe-chemo-approach/#post-161 Unfortunately, Meech did not responded.
While I like Medicore, 90% response rate claim is huge indeed, but I think this statement on the Medicore website may bring some more clarifications: "It is not a simple therapy, but when it is done correctly in the right patients, it can work quickly and safely and give excellent results."
So one important points is that they are selecting the patients.
Another point that is often misleading for the patients is the notion of "response". Response can also imply short therm regression followed soon by growth of the tumour, sometimes even faster than before. So always the questions is not so much about the response rate but about facts supporting the survival increase compared to the conventional treatment options.